Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00676780 · ClinicalTrials.gov registry record · Phase 2
Green Tea Extract and Prostate Cancer
A Phase 2 study, sponsored by Louisiana State University Health Sciences Center Shreveport.
- Completed
- Registry status
- Phase 2
- Development phase
- 33
- Enrollment target
NCT00676780 is a Phase 2 study that has completed, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 33 participants.
The verdict
NCT00676780, a Phase 2 study, has completed, sponsored by Louisiana State University Health Sciences Center Shreveport.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of the study is to see if a green tea extract can beneficially alter several markers of cancer risk and progression.
Interventions
- DRUG Polyphenon E (EGCG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2004-05 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00676780
The ClinicalTrials.gov registry entry for NCT00676780 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center Shreveport, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Polyphenon E (EGCG) is the first listed.
NCT00676780 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00676780 about?
NCT00676780 is a clinical study titled "Green Tea Extract and Prostate Cancer". The purpose of the study is to see if a green tea extract can beneficially alter several markers of cancer risk and progression.
What is the current status of trial NCT00676780?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 33 participants. The study started on 2004-05. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00676780?
The interventions under investigation include: Polyphenon E (EGCG) (DRUG).
Who is sponsoring clinical trial NCT00676780?
This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.